Shedding of viable SARS-COV-2 after immunosuppressive therapy for cancer Research Letter

   

Authors:	Aydillo, T.; Gonzalez-Reiche, A. S.; Aslam, S.; van de Guchte, A.; Khan, Z.; Obla, A.; Dutta, J.; van Bakel, H.; Aberg, J.; García-Sastre, A.; Shah, G.; Hohl, T.; Papanicolaou, G.; Perales, M. A.; Sepkowitz, K.; Babady, N. E.; Kamboj, M.
Title:	Shedding of viable SARS-COV-2 after immunosuppressive therapy for cancer
Journal Title:	New England Journal of Medicine
Volume:	383
Issue:	26
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2020-12-24
Start Page:	2586
End Page:	2588
Language:	English
DOI:	10.1056/NEJMc2031670
PUBMED:	33259154
PROVIDER:	scopus
PMCID:	PMC7722690
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098663250&doi=10.1056%2fNEJMc2031670&partnerID=40&md5=d716ce455e71ce803057756aaf08e859
Notes:	Letter -- Export Date: 1 February 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/176038